2Sakurai Y, Uchida M,Aiba J,et al. Effects of pregnancy on the onset time of rocumnium[ J]. Masui ,2014,63 ( 3 ) : 324-327.
3Abu-Halaweh SA, Massad IM, Abu-Ali HM, et al. Rapid sequence induction and intubation with 1 mg/kg rocuronium bromide in cesar- ean section, comparison with suxamethonium [ J ]. Saudi Medical Journal,2007,28, (9) : 1393-1396.
4Adamus M, Hrabalek L, Wanek T, et al. Influence of age and gender on the pharmacodynamic parameters of rocuronium during total intra- venous anesthesia[ J]. Biomed Pap Med Fae Univ Palacky Olomouc Czech Repub ,2011,155 (4) :347-353.
5Sung-Joon Cho, ]n-Soo Yoon, Dae-Duk Kim. Obesity-related physio- logical changes and their pharmacokinetic consequences [ J ]. Journal of Pharmaeeutieal Investigation, 2013,43 ( 3 ) : 161-169.
6Viby-Mogensen J, Engbaek J, Eriksson Li, et al. Good clinical re- search practice (GCRP) in phamaeodynamic studies of neuromuscular blocking agents [ J ]. Acta Anaesthesiol Scand. 1996.40 ( 1 ) 59 -74.
7Shibusawa M, Ejima Y, Nishino R, et al. Use of sugammadex in pa- tients undergoing caesarean section using general anesthesia with mcuronium [ J ]. Masui, 2012,61 ( 8 ) : 805-809.
8Politis GD,Brill J,Jones J,et al. Use of low-dose rocuronium for in- tubation of children during volunteer surgery abroad [ J ]. Pediatric Anesthesia,2005,15 ( 8 ) :648-652.
9Viby-Mogersen J, Enghack J, Eriksson Li, et al. Good clinical research practice ( GCRP ) in phamacodynamic studies of neuromuscular blocking agents [ J ]. Acta Anaesthesiol Seand, 1996, 40( 1 ) :59-74.
10Shibusama M, Ejima Y, Nishino R, et al. Usa of sugammadex in patients undergoing caesarean section using general anesthesia with rocuronium[ J]. Masui,2012,61 (8) :805-809.